CLOs on the Move

Versartis

www.versartis.com

 
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

DNA2.0

DNA2.0 is a privately-held, leading synthetic genomics company, headquartered in Menlo Park, CA.

HealthTrans

HealthTrans is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Shape Up The Nation

Shape Up The Nation is the first corporate wellness company focused on leveraging the power of trusted social networks to promote healthy living.

CareJourney

CareJourney is a leading provider of clinically-relevant analytics for value-based networks. Headquartered in Arlington, VA, CareJourney currently supports leading payer, provider, and life sciences organizations across the US in achieving their goals by wringing new, high value insights out of expansive population claims data. Through its CareJourney Platform, CareJourney provides members with interactive dashboards of clinically-relevant insights around network design and management, care model management, patient risk segmentation, spend and utilization trends, network integrity, low-value care, and provider, practice and facility (acute and post-acute) performance.

Ardian

Ardian is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.